Exact Mass: 431.9942046
Exact Mass Matches: 431.9942046
Found 52 metabolites which its exact mass value is equals to given mass value 431.9942046,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
5-Chloro-4-N-(cyclopropylmethyl)-2-methyl-4-N-propyl-6-N-(2,4,6-trichlorophenyl)pyrimidine-4,6-diamine
C18H20Cl4N4 (432.04420000000005)
5-BROMO-6-CHLORO-3-INDOLYL PHOSPHATE P-TOLUIDINE SALT
C15H15BrClN2O4P (431.96412900000007)
2-(Perfluorohexyl)ethyl methacrylate
C12H9F13O2 (432.03949299999994)
Methyl 8-iodo-4,5,6,7-tetramethoxy-2-naphthoate
C16H17IO6 (432.00698520000003)
2-(perfluoropropoxy)perfluoropropyl trifluorovinyl ether
Clometocillin
C17H18Cl2N2O5S (432.03134380000006)
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CE - Beta-lactamase sensitive penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
DIMETHYL 2-(3-BROMO-5-FORMYL-4-((2-METHOXYETHOXY)METHOXY)PHENYL)SUCCINATE
Disodium 3,3-carbonylbis(4-hydroxy-6-methoxybenzenesulfonate)
5-bromo-4-chloro-3-indoxyl sulfate p-toluidine salt
C15H14BrClN2O4S (431.9546134000001)
4-(3-Bromo-2-thienyl)-1-[(4-methylphenyl)sulfonyl]-1H-pyrrolo[2,3 -b]pyridine
3-IODO-N-(2-MORPHOLIN-4-YL-ETHYL)-BENZENESULFONAMIDE HYDROCHLORIDE
C12H18ClIN2O3S (431.97713780000004)
Chloro(methyldiphenylphosphine)gold(I),95
C13H13AuClP (432.01089580000007)
3-Acetoxymercuri-4-aminobenzenesulfonamide
C8H10HgN2O4S (432.00675800000005)
D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
2-[5-[(3,4-Dichlorophenyl)methylthio]-4-(thiophen-2-ylmethyl)-1,2,4-triazol-3-yl]pyridine
5-(4-Dibenzothiophenyl)-4-[(1-methyl-5-tetrazolyl)thio]thieno[2,3-d]pyrimidine
3-bromo-N-[5-(4-morpholinylsulfonyl)-1,3,4-thiadiazol-2-yl]benzamide
C13H13BrN4O4S2 (431.95615580000003)
2-fluoro-N-[2,2,2-trichloro-1-[[(4-methoxy-2-nitroanilino)-sulfanylidenemethyl]amino]ethyl]acetamide
C12H12Cl3FN4O4S (431.96288540000006)
5-Chloro-4-N-(cyclopropylmethyl)-2-methyl-4-N-propyl-6-N-(2,4,6-trichlorophenyl)pyrimidine-4,6-diamine
C18H20Cl4N4 (432.04420000000005)
2,6-Dichloro-2',3',5'-triacetyl-purine riboside
2,6-Dichloro-2',3',5'-triacetyl-purine riboside is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
P2Y2R/GPR17 antagonist 1
C19H13ClN2O6S (432.01828280000007)
P2Y2R/GPR17 antagonist 1 (Compound 14m) is a dual P2Y2R and GPR17 antagonist with IC50 values of 3.17 μM and 1.67 μM against P2Y2R and GPR17, respectively. P2Y2R/GPR17 antagonist 1 shows excellent metabolic stability in human liver microsomes[1].
(5s,8r,9r)-9-(2,4-dibromo-5-methoxyphenyl)-8-hydroxy-7-methyl-1,7-diazaspiro[4.4]nonan-6-one
2-{[(5z)-5-{3-[(4-bromo-1h-pyrrol-2-yl)formamido]propylidene}-2-iminoimidazolidin-4-ylidene]amino}ethanesulfonic acid
C13H17BrN6O4S (432.02153020000003)
(1r,7s,8s,11r)-11-(hydroxymethyl)-17-methyl-10,16-dioxo-12,13,14,15-tetrathia-9,17-diazatetracyclo[9.4.2.0¹,⁹.0³,⁸]heptadeca-3,5-dien-7-yl acetate
5-{2-[2-(2-{[2,2'-bithiophen]-5-yl}ethynyl)cyclobutyl]ethynyl}-2,2'-bithiophene
4-chloro-7-(3,5-dichloro-2,4-dimethoxy-6-methylphenoxy)-5-methoxy-3h-2-benzofuran-1-one
2-[(5-{3-[(4-bromo-1h-pyrrol-2-yl)formamido]propylidene}-2-iminoimidazolidin-4-ylidene)amino]ethanesulfonic acid
C13H17BrN6O4S (432.02153020000003)